JM
Therapeutic Areas
Nyrada Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Xolatryp | Cardioprotection (STEMI) and Neuroprotection (stroke, TBI) | Phase 1 |
| PCSK9 inhibitor | Hypercholesterolemia (statin‑resistant) | Preclinical |
| Peripheral nerve pain agent | Neuropathic pain | Preclinical |
| Autoimmune psoriasis candidate | Psoriasis | Preclinical |